Alonso MOL, Alonso MAL, Capote VB

Language: Spanish
References: 10
Page: 68-70
PDF size: 265.39 Kb.

ABSTRACT

Transfusion of blood and blood components require a constant and critical clinical evaluation taking into account its risk and the high proportion of indicated transfusions. A study was carried out at «Dr. Celestino Hernández Robau» University Hospital from January to December, 2014 in order to know the use of blood and blood components and do its evaluation. A number of 2703 patients received 5986 transfusions; more than half of these transfusions corresponded to the Oncology Service. The most used component was erythrocyte concentrate, followed by, platelet concentrate and antihemophilic plasma. Incomplete and incorrect indications were detected, transfusions were based more on results than clinical manifestations, as well as, medical opinion was not always reflected in patient’s medical record.

REFERENCES

1. Leal Noval Z, Muñoz M, Asuero M, Contreras EJ, García Erce A, Llau J V, et al. Documento «Sevilla» de Consenso sobre alternativas a la transfusión de sangre alogénica. Farm Hosp. 2013;37(3):209-35.

2. Delgado MB. Transfusión sanguínea. Uso racional. Rev Colomb Anestesiol. 2012;40(4):247-8.

3. Maldonado Rojas M, Piña Farías L, Vásquez Rojas M, Toro Opazo C. Complicaciones asociadas a la transfusión masiva. Rev Cubana Hematol Inmunol Hemoter [internet]. 2013 jul.-sep. [citado 17 abr. 2015]; 29(3):[aprox. 13 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892013000300005&lng=es&nrm=iso&tlng=es

4. Currya N, Davenport RA, Huntc BJ, Stanwortha SJ. Transfusion strategies for traumatic coagulopathy. Blood. 2012;26:223-32.

5. Leal Noval S, Fernández E, Arellano V, Martínez C. Efectos adversos de la transfusión de sangre conservada. ¿Qué hay de verdad y qué se puede hacer? Haematologica. 2011;96(1):25-9.

6. Adam RC, Lundy JS. Anestesia in cases of poor surgical risks: some suggestions for decreasing the risk. Surg Gynecol Obstet. 1942;74: 1011- 9.

7. Meibner A, Schlenke P. Massive Bleeding and Massive Transfusion. Transfus Med Hemother. 2012;39(2):73-84.

8. Bittencourt R, Costa J, de Oliveira Lobo JE, Costa Aguiar F. Transfusión consciente de hemoderivados. Revisión sistemática de los factores indicativos del gatillo para la infusión de los componentes sanguíneos. Rev Bras Anestesiol. 2012;62(3):402-10.

9. Madrazo González Z, García Barrasa A, Rodríguez Lorenzo L, Rafecas Renata A, Alonso Fernández G. Actualización en anemia y terapia transfusional. Med Intensiva. 2011;35(1):32-40.

10. Leal-Noval SR, Arellano V, Maestre A, Muñoz M, Fernández V, Ferrándiz C, et al. Impact of national transfusion indicators on appropriate Blood usage in critically ill patients. Transfusion. 2011;51:1957-65.